EXPERIENCE OF TREATMENT WITH GENERIC LAMOTRIDJIN IN DIFFERENT FORMS OF EPILEPSY (The results of focus observation in out-patient clinics network of Moscow city public healthcare services)
Abstract
Focused observational study on efficacy, tolerability and quality of life in adult patients with different forms of epilepsy taking combined therapy with lamotrigine (Sazar). 32 patients (19 men and 13 women), 23-79 years old with focal forms (cryptogenic and symptomatic) epilepsy with different disease duration and presence of of different type and etiology seizures were enrolled into the study. Patients having been taken various antiepileptic drugs in monotherapy with different efficacy degree were observed. Patients sample included 20 patients, receiving valproic acid in various dosages and 12 patients, receiving topiramate. Sazar was added as a second drug with initial dosage of 25 mg daily. Results of focused observation allow us to make conclusion of possible expedience of Sazar indication, especially in patients in whom therapy with valproic acid is less effective.
About the Authors
O. L. Badalyan
City polyclinics, Moscow
Russian Federation
Russian Federation
M. A. Bogomazova
City polyclinics, Moscow
Russian Federation
Russian Federation
I. I. Zhuravleva
City polyclinics, Moscow
Russian Federation
Russian Federation
A. M. Ismailov
City polyclinics, Moscow
Russian Federation
Russian Federation
. .
City polyclinics, Moscow
Russian Federation
Russian Federation
E. G. Komelkova
City polyclinics, Moscow
Russian Federation
Russian Federation
L. N. Lesinker
City polyclinics, Moscow
Russian Federation
Russian Federation
Yu. I. Logvinov
City polyclinics, Moscow
Russian Federation
Russian Federation
O. V. Otcheskaya
City polyclinics, Moscow
Russian Federation
Russian Federation
S. V. Petrov
City polyclinics, Moscow
Russian Federation
Russian Federation
Yu. V. Solomatin
City polyclinics, Moscow
Russian Federation
Russian Federation
A. M. Teplysheva
City polyclinics, Moscow
Russian Federation
Russian Federation
T. N. Udovuchenko
City polyclinics, Moscow
Russian Federation
Russian Federation
A. E. Khromykh
City polyclinics, Moscow
Russian Federation
Russian Federation
A. S. Chukanova
City polyclinics, Moscow
Russian Federation
Russian Federation
A. V. Lebedeva
City polyclinics, Moscow
Russian Federation
Russian Federation
S. G. Burd
GBOU VPO RNIMU named after N.I. Pirogov, Moscow
Russian Federation
Russian Federation
A. N. Boiko
GBOU VPO RNIMU named after N.I. Pirogov, Moscow
References
1. Дробижев М.Ю. Психиатрия и психофармакотерпия. 2007; 9 (3).
2. Borgheini G. Clin Ther. 2003 Jun; 25(6): 1578-92.
3. Duh M.S., Andermann F., Paradis P.E., Weiner J., Manjunath R., Cr mieux P.Y. Dis Manag. 2007 Aug; 10 (4): 216-25.
4. Bialer M. Epilepsia. 2007 Oct; 48 (10): 1825-32.
5. Andermann F., Duh M.S., Gosselin A., Paradis P.E. Epilepsia. 2007 Mar; 48 (3): 464-9.
6. Chow S.C., Liu J.J. Biopharm Stat. 1997 Mar; 7 (1): 97-111.
7. Heaney D.C., Sander J.W. Lancet Neurol. 2007 May; 6 (5): 465-8.
8. Lee C.Y., Fu W.M., Chen C.C., Su M.J., Liou H.H. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia. 2008 May; 49 (5): 888-97.
9. Liu G., Yarov-Yarovoy V., Nobbs M., Clare J.J., Scheuer T., Catterall W.A. Differential interactions of lamotrigine and related drugs with transmembrane segment IVS6 of voltage-gated sodium channels. Neuropharmacology. 2003; 44 (3): 413-22.
10. Buck T.C., Schmedes A. Brandslund IUgeskr Laeger. 2007 May 21; 169 (21): 2013-5.
11. Xie X., Lancaster B., Peakman T., Garthwaite J. Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones Pflugers Arch. 1995; 430 (3): 437-46.
12. Zona C., Tancredi V., Longone P., D’Arcangelo G., D’Antuono M., Manfredi M., Avoli M. Neocortical potassium currents are enhanced by the antiepileptic drug lamotrigine. Epilepsia. 2002; 43 (7): 685-90.
Review
For citations:
Badalyan O.L., Bogomazova M.A., Zhuravleva I.I., Ismailov A.M., . , Komelkova E.G., Lesinker L.N., Logvinov Yu.I., Otcheskaya O.V., Petrov S.V., Solomatin Yu.V., Teplysheva A.M., Udovuchenko T.N., Khromykh A.E., Chukanova A.S., Lebedeva A.V., Burd S.G., Boiko A.N. EXPERIENCE OF TREATMENT WITH GENERIC LAMOTRIDJIN IN DIFFERENT FORMS OF EPILEPSY (The results of focus observation in out-patient clinics network of Moscow city public healthcare services). Epilepsy and paroxysmal conditions. 2012;4(4):40-48. (In Russ.)
Views: 530
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
